Evidence map›Paper›PMID 26294958›Full record

ArticleRSC advances2015

Antimicrobial Peptide-Conjugated Graphene Oxide Membrane for Efficient Removal and Effective Killing of Multiple Drug Resistant Bacteria.

Rajashekhar Kanchanapally, Bhanu Priya Viraka Nellore, Sudarson Sekhar Sinha, Francisco Pedraza, Stacy J Jones, Avijit Pramanik, Suhash Reddy Chavva, Christine Tchounwou, Yongliang Shi, Aruna Vangara and 2 more

Open access · greenAbstract read
In one paragraph

Article in RSC advances, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 136 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Graphene Biosensors-A Molecular Approach.Nanomaterials (Basel, Switzerland) · 2022
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Rajashekhar KanchanapallyDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Bhanu Priya Viraka NelloreDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Sudarson Sekhar SinhaDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Francisco PedrazaDepartment of Physics and Astronomy, University of Texas at San Antonio, TX, USA.
Stacy J JonesDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Avijit PramanikDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Suhash Reddy ChavvaDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Christine TchounwouDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Yongliang ShiDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Aruna VangaraDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Dhiraj SardarDepartment of Physics and Astronomy, University of Texas at San Antonio, TX, USA.
Paresh Chandra RayDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, MS, USA.
Jackson State University · USJackson College · USThe University of Texas at San Antonio · US

Funding

UTSA RISE Research Training ProgramR25GM060655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI BAREA-RODRIGUEZ, EDWIN J · 2000 to 2022
$21.6M
RCMI-Center for Environmental HealthG12MD007581 · NIMHD · JACKSON STATE UNIVERSITY · PI TCHOUNWOU, PAUL B. · 2012 to 2017
$11.2M
RCMI Center for Interdiscplinary Health Research CIHRG12MD007591 · NIMHD · UNIVERSITY OF TEXAS SAN ANTONIO · PI PERRY, GEORGE · 2012 to 2016
$10.4M
NIGMS NIH HHS R25 GM060655NIMHD NIH HHS G12 MD007581NIMHD NIH HHS G12 MD007591
6 · The paper itself

Abstract

According to the World Health Organization (WHO), multiple drug-resistant (MDR) bacterial infection is a top threat to human health. Since bacteria evolve to resist antibiotics faster than scientists can develop new classes of drugs, the development of new materials which can be used, not only for separation, but also for effective disinfection of drug resistant pathogens is urgent. Driven by this need, we report for the first time the development of a nisin antimicrobial peptide conjugated, three dimensional (3D) porous graphene oxide membrane for identification, effective separation, and complete disinfection of MDR methicillin-resistant

Identifiers

PMID26294958
PMCPMC4539267
OpenAlexW2081940512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.